Edition:
United States

ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

27.15USD
2 Dec 2016
Change (% chg)

$0.67 (+2.53%)
Prev Close
$26.48
Open
$26.63
Day's High
$27.66
Day's Low
$26.08
Volume
1,508,255
Avg. Vol
2,326,812
52-wk High
$42.49
52-wk Low
$16.64

Latest Key Developments (Source: Significant Developments)

BRIEF-Acadia Pharmaceuticals initiates phase II trial of Pimavanserin

* Acadia Pharmaceuticals initiates phase II trial of Pimavanserin for adjunctive treatment in patients with negative symptoms of schizophrenia Source text for Eikon: Further company coverage: